1536348603
Latest Interviews - Finance News Network

Advertise on podcast: Latest Interviews - Finance News Network

This podcast has
50 episodes
Language
English
Date created
2020/10/18
Latest episode
2026/10/13
Average duration
-
Release period
11 days

Description

The latest Interviews from Finance News Network.

Unlock Latest Interviews - Finance News Network podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Social media

Check Latest Interviews - Finance News Network social media presence


Podcast episodes

Check latest episodes from Latest Interviews - Finance News Network podcast


Immutep outlines clinical development priorities and plans for 2027
2026/10/13
14 Oct 2026 - CEO Marc Voigt discusses the next steps for efti and IMP761, including potential Phase II trials and upcoming clinical milestones.
Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma
2026/09/16
17 Sept 2026 - CEO Marc Voigt outlines Immutep’s focused clinical strategy, ongoing TACTI-004 analysis and plans to return efti to the clinic in 2027.
Senetas Corporation positioned for further capital returns as outlook strengthens
2026/09/14
14 Sept 2026 - Trim Capital says Senetas’ strong cash position, positive sales outlook and expanding global opportunities provide scope for further capital management and growth.
Clever Culture Systems builds commercial momentum with global pharma expansion
2026/09/08
08 Sept 2026 - CEO Brent Barnes discusses the growing adoption of APAS Independence, the company’s Land and Expand strategy and the outlook for FY27.
IVE Group delivers on FY26 guidance as growth initiatives take shape
2026/09/07
07 Sept 2026 - CEO Matt Aitken discusses IVE Group’s FY26 performance, the new Kemps Creek supersite, 3PL expansion, recent acquisitions and the growing role of AI across the business.
Djerriwarrh Investments (ASX: DJW) delivers an enhanced yield of 2.9% above the S&P/ASX 200 Index
2026/08/12
12 Aug 2026 - Djerriwarrh Investments options strategy delivers an enhanced income while maintaining a diversified portfolio of quality companies.
AMCIL (ASX: AMH) sees opportunity in quality stocks as market volatility creates value
2026/08/11
11 Aug 2026 - AMCIL says recent market volatility has created attractive buying opportunities as it remains focused on investing in quality companies for the long term.
Mirrabooka Investments (ASX: MIR) despite a tough year quality opportunities emerge
2026/08/10
10 Aug 2026 - Mirrabooka Investments says recent portfolio refinements and improving valuations are creating opportunities for long-term investors.
Australian Foundation Investment Company (ASX: AFI) declares a fully franked special dividend of 5 cents per share in FY26
2026/08/07
07 Aug 2026 - Australian Foundation Investment Company continues to reward shareholders through fully franked dividends while positioning the portfolio for long-term growth.
Immutep highlights encouraging survival data and key clinical milestones
2026/07/15
15 July 2026 - CEO and Executive Director Marc Voigt discusses new INSIGHT-003 results, ongoing clinical analysis and upcoming catalysts
CSL partnership validates Clever Culture’s global growth strategy
2026/06/12
12 June 2026 - Brent Barnes discusses the significance of adding CSL as the company’s eighth top-20 pharmaceutical customer
Janus Electric funded for growth as global expansion gains momentum
2026/06/09
09 June 2026 - Fresh funding and US momentum support Janus Electric's growth strategy
RFM’s Matt Mitchell charts Australia’s cotton future
2026/06/01
01 June 2026 - Australia’s premium cotton - driven by our unique growing environment - underpins RFM’s expansion strategy in Central Queensland.
Chilwa Minerals expands Malawi laboratory operations through Lindian agreement
2026/05/28
28 May 2026 - Lindian Resources has engaged Chilwa’s Zalewa laboratory to support drilling and sample preparation activities at Kangankunde
Immutep advances autoimmune program while reviewing efti pathway
2026/05/18
18 May 2026 - Mark Voigt, CEO and Executive Director of Immutep, discusses the company’s strategic priorities following the discontinuation of its Phase III TACTI-004 lung cancer trial

Podcast reviews

Read Latest Interviews - Finance News Network podcast reviews


0 out of 5
0 reviews

Podcast sponsorship advertising

Start advertising on Latest Interviews - Finance News Network relevant audience podcasts


What do you want to promote?